-
Y-27632: ROCK Inhibition for Translational iPSC Models
2026-08-29
A mechanistic and strategic guide to using Y-27632 as a controlled cytoskeletal perturbation in iPSC-derived airway models, with practical protocol considerations and translational limitations.
-
GS-441524 Workflows for LC–MS/MS Research
2026-08-28
Build more reliable antiviral and pharmacokinetic studies with a workflow that treats GS-441524 as both a biological reagent and a matrix-sensitive analytical target. The approach combines controlled DMSO formulation, parent–metabolite tracking, LC–MS/MS confirmation, and practical troubleshooting for SARS-CoV-2 research.
-
Oleanolic Acid, FXR, and Cholestatic Liver Injury
2026-08-28
The reference study identifies a linked mechanism in which oleanolic acid impairs hepatocyte tight junctions and suppresses FXR-associated bile acid efflux through BSEP and MRP2. Its combined in vivo, in vitro, imaging, and LC-MS/MS strategy provides a useful framework for studying cholestatic drug-induced liver injury and FXR-dependent transport regulation.
-
Quizartinib (AC220) for FLT3 Research
2026-08-27
Quizartinib (AC220) combines low-nanomolar FLT3 activity with a practical workflow for AML signaling, resistance, and xenograft studies. This guide translates its selectivity into assay design, troubleshooting decisions, and cross-disease applications without treating preclinical findings as clinical conclusions.
-
From TIL Biology to Better Fluorescence Data
2026-08-27
Tumor-microenvironment modulation can improve TIL yield and function, but translational decisions depend on measurement quality. This article connects the mechanistic findings of a recent microsphere-enabled TIL study with practical strategies for using the FITC Goat Anti-Mouse IgG (H+L) Antibody in immunofluorescence and flow cytometry, while addressing controls, workflow fit, and preclinical limitations.
-
3-Deazaadenosine hydrochloride: Causal Assay Guide
2026-08-26
3-Deazaadenosine hydrochloride is an S-adenosylhomocysteine hydrolase inhibitor for dissecting methylation-dependent biology. This guide translates recent IGF2BP1–m6A–TUBB4B findings into a rigorous, orthogonal assay strategy for HSC and inflammation research.
-
GPNMB-Based Model Predicts ESCC Immunotherapy Response
2026-08-26
This reference study identifies circulating soluble GPNMB as a biomarker and mechanistic driver of resistance to PD-1 blockade in esophageal squamous cell carcinoma. By integrating plasma GPNMB, CAF-epithelial niche features, and clinicopathological variables, the authors develop a multimodal framework for response and survival prediction.
-
GS-441524: From Prodrug Biology to Assay Design
2026-08-25
Explore how GS-441524 chemistry, bioactivation, and matrix-specific LC–MS/MS analysis shape antiviral research. This guide translates recent prodrug-conversion findings into practical decisions for GS-441524 pharmacokinetics, sample handling, and assay interpretation.
-
3-Deazaadenosine in Reliable Cell Assays
2026-08-25
A scenario-based guide to using 3-Deazaadenosine (SKU B6121) in cell viability, proliferation, cytotoxicity, and methylation studies. It connects assay design, formulation, data interpretation, vendor selection, and preclinical antiviral research to documented mechanistic and product information.
-
Remdesivir (GS-5734): An Assay-First Framework
2026-08-24
Remdesivir (GS-5734) is examined through an assay-first lens that connects polymerase pharmacology with translational antiviral study design. Insights from recent Bourbon virus research clarify how to interpret potency, timing, and tissue-level outcomes without overstating cross-virus evidence.
-
GS-441524: Mechanism, PK, and Research Workflows
2026-08-24
GS-441524 is an adenine nucleoside analog studied for conversion to an active triphosphate antiviral metabolite. Recent LC–MS/MS work maps GS-441524 prodrug conversion across gastric, blood, liver, and animal pharmacokinetic models, while product-specific handling data define solvent, storage, and quality-control requirements.
-
Diphenyleneiodonium chloride for Reliable Assays
2026-08-23
Learn how Diphenyleneiodonium chloride (DPI, SKU B6326) can clarify redox-dependent viability results, cAMP signaling modulation, and oxidative stress experiments. This scenario-based guide covers formulation, controls, protocol optimization, interpretation, and practical product selection.
-
Moxifloxacin Workflows for Gyrase and Toxicity
2026-08-22
Build reproducible Moxifloxacin assays that connect bacterial DNA gyrase inhibition with retinal ganglion cell viability and metabolic-response studies. This guide combines fresh-solution handling, concentration design, mechanistic controls, and troubleshooting for antibiotic toxicity research.
-
TBXA2R–ERM Signaling in TNBC Metastasis
2026-08-21
The reference study identifies TBXA2R as an upstream GPCR activator of ezrin, radixin, and moesin, linking receptor signaling to cytoskeletal remodeling in triple-negative breast cancer. Its results connect G-protein, Rho GTPase, and SLK/LOK kinase signaling with tumor-cell motility, invasion, and metastatic colonization, while highlighting ERM function as a mechanistic dependency.
-
GS-441524: Mechanism, Evidence, and Research Use
2026-08-21
GS-441524 is a nucleoside analog that can be phosphorylated intracellularly to an active triphosphate metabolite targeting viral RNA synthesis. Current evidence supports GS-441524 antiviral research, prodrug-conversion studies, and pharmacokinetic assay development, but product purity and in vitro activity should not be interpreted as clinical efficacy.